Wealthink AI-Innovation Capital Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Wealthink AI-Innovation Capital.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Capital Markets	17.2%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

What Kind Of Investors Own Most Of Wealthking Investments Limited (HKG:1140)?

Mar 18

Wealthking Investments' (HKG:1140) Shareholders Are Down 71% On Their Shares

Feb 11

Zhiwei Liu Is The Executive Chairman of the Board of Wealthking Investments Limited (HKG:1140) And They Just Picked Up 65% More Shares

Jan 07

What Type Of Shareholders Make Up OP Financial Limited's (HKG:1140) Share Registry?

Dec 15

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Wealthink AI-Innovation Capital no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

SEHK:1140 - Estimaciones futuras de los analistas y datos financieros pasados (HKD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
9/30/2023	255	-44	-53	-49	N/A
6/30/2023	224	51	-76	-73	N/A
3/31/2023	193	146	-100	-96	N/A
12/31/2022	162	192	14	13	N/A
9/30/2022	131	238	127	123	N/A
6/30/2022	113	229	48	47	N/A
3/31/2022	95	221	-31	-28	N/A
12/31/2021	105	183	-135	-130	N/A
9/30/2021	114	144	-238	-231	N/A
6/30/2021	113	258	-146	-143	N/A
3/31/2021	112	373	-54	-54	N/A
12/31/2020	118	-420	-80	-75	N/A
9/30/2020	124	-1,213	-106	-96	N/A
6/30/2020	153	-1,293	-109	-96	N/A
3/31/2020	182	-1,373	-113	-95	N/A
12/31/2019	199	-407	-45	-30	N/A
9/30/2019	216	558	22	34	N/A
6/30/2019	230	407	-61	-53	N/A
3/31/2019	245	257	-145	-140	N/A
12/31/2018	231	117	-230	-227	N/A
9/30/2018	217	-23	-315	-313	N/A
6/30/2018	171	60	-264	-264	N/A
3/31/2018	125	143	-214	-214	N/A
12/31/2017	112	221	8	8	N/A
9/30/2017	98	298	231	231	N/A
6/30/2017	100	243	N/A	136	N/A
3/31/2017	102	188	N/A	41	N/A
12/31/2016	82	105	N/A	-214	N/A
9/30/2016	63	21	N/A	-469	N/A
6/30/2016	46	33	N/A	-264	N/A
3/31/2016	29	44	N/A	-59	N/A
12/31/2015	27	38	N/A	-16	N/A
9/30/2015	24	31	N/A	28	N/A
6/30/2015	28	14	N/A	45	N/A
3/31/2015	32	-3	N/A	62	N/A
12/31/2014	36	14	N/A	93	N/A
9/30/2014	40	31	N/A	123	N/A
6/30/2014	36	39	N/A	52	N/A
3/31/2014	31	47	N/A	-19	N/A
12/31/2013	28	36	N/A	105	N/A
9/30/2013	25	24	N/A	229	N/A
6/30/2013	27	18	N/A	236	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de 1140 es superior a la tasa de ahorro (2%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de 1140 crezcan más rápidamente que el mercado Hong Kong

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de 1140 crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de 1140 crezcan más rápidamente que el mercado de Hong Kong.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de 1140 crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de 1140 se prevé que sea elevada dentro de 3 años.

Wealthink AI-Innovation Capital Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Now 34% undervalued

First half 2024 earnings released: EPS: HK$0.002 (vs HK$0.032 in 1H 2023)

Wealthink AI-Innovation Capital Limited to Report First Half, 2024 Results on Nov 29, 2023

Now 48% undervalued after recent price drop

Full year 2023 earnings released: EPS: HK$0.018 (vs HK$0.064 in FY 2022)

Wealthking Investments Limited, Annual General Meeting, Aug 25, 2023

Now 20% undervalued after recent price drop

New minor risk - Profit margin trend

Full year 2023 earnings released: EPS: HK$0.02 (vs HK$0.064 in FY 2022)

Less than half of directors are independent

Wealthking Investments Limited to Report Fiscal Year 2023 Results on Jun 21, 2023

Wealthking Investments Limited Announces Board Changes

Wealthking Investments Limited Announces Appointment of Wang Qin as Non-Executive Director and Co-Chairman of the Board

Now 24% undervalued after recent price drop

CEO & Executive Chairman recently bought HK$53k worth of stock

First half 2023 earnings released: EPS: HK$0.032 (vs HK$0.066 in 1H 2022)

CEO & Executive Chairman recently bought HK$125k worth of stock

First half 2023 earnings released: EPS: HK$0.032 (vs HK$0.066 in 1H 2022)

Wealthking Investments Limited to Report Q2, 2022 Results on Nov 25, 2022

Now 21% undervalued after recent price drop

Wealthking Investments Limited has completed a Follow-on Equity Offering in the amount of HKD 802.575311 million.

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Full year 2022 earnings released: EPS: HK$0.064 (vs HK$0.13 in FY 2021)

Wealthking Investments Limited, Annual General Meeting, Aug 26, 2022

Wealthking Investments Limited has completed a Follow-on Equity Offering in the amount of HKD 406.1316 million.

Now 20% undervalued after recent price drop

Now 23% undervalued after recent price drop

Full year 2022 earnings released: EPS: HK$0.06 (vs HK$0.13 in FY 2021)

Wealthking Investments Limited to Report Fiscal Year 2021 Results on Jun 24, 2022

Executive Chairman of the Board recently bought HK$501k worth of stock

Wealthking Investments Limited Announces Changes to Non-Executive Directors and Composition of Board Committees

Executive Chairman of the Board recently bought HK$2.7m worth of stock

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Executive Chairman of the Board recently bought HK$6.6m worth of stock

Wealthking Investments Limited has completed a Follow-on Equity Offering in the amount of HKD 382.92408 million.

Executive Chairman of the Board recently bought HK$892k worth of stock

Executive Chairman of the Board recently bought HK$107k worth of stock

Executive Chairman of the Board recently bought HK$163k worth of stock

Full year 2021 earnings released: EPS HK$0.13 (vs HK$0.47 loss in FY 2020)

Executive Chairman of the Board recently bought HK$11m worth of stock

Full year 2021 earnings released: EPS HK$0.13 (vs HK$0.47 loss in FY 2020)

Head of Legal, Compliance & Risk Management and Company Secretary Tao Zhou has left the company

Head of Legal, Compliance & Risk Management and Company Secretary Tao Zhou has left the company

What Kind Of Investors Own Most Of Wealthking Investments Limited (HKG:1140)?

Wealthking Investments' (HKG:1140) Shareholders Are Down 71% On Their Shares

New 90-day high: HK$1.00

Zhiwei Liu Is The Executive Chairman of the Board of Wealthking Investments Limited (HKG:1140) And They Just Picked Up 65% More Shares

First half 2021 earnings released: EPS HK$0.15

Wealthking Investments Limited Announces CEO Changes

What Type Of Shareholders Make Up OP Financial Limited's (HKG:1140) Share Registry?

First half 2021 earnings released: EPS HK$0.15

OP Financial Limited to Report First Half, 2021 Results on Nov 27, 2020

New 90-day low: HK$0.76

OP Financial Limited(SEHK:1140) dropped from S&P Global BMI Index

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento